Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Injection

Riepilogo

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Phoenix Pharmaceutical, Inc. The ANADA provides for intravenous use of oxytetracycline hydrochloride injection in cattle for treatment of certain diseases caused by pathogens sensitive to oxytetracycline. EFFECTIVE DATE: September 20, 1995. FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center For Veterinary Medicine (HFV-135), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-594-1643.